Charles Schwab’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.7M Buy
1,822,322
+54,728
+3% +$443K ﹤0.01% 1827
2025
Q1
$14.8M Buy
1,767,594
+227,660
+15% +$1.91M ﹤0.01% 1775
2024
Q4
$12.2M Buy
1,539,934
+135,051
+10% +$1.07M ﹤0.01% 1929
2024
Q3
$11.7M Buy
1,404,883
+202,863
+17% +$1.69M ﹤0.01% 1954
2024
Q2
$7.63M Sell
1,202,020
-28,314
-2% -$180K ﹤0.01% 2163
2024
Q1
$7.46M Sell
1,230,334
-99,174
-7% -$601K ﹤0.01% 2129
2023
Q4
$8.07M Buy
1,329,508
+26,875
+2% +$163K ﹤0.01% 2101
2023
Q3
$5.5M Buy
1,302,633
+47,599
+4% +$201K ﹤0.01% 2207
2023
Q2
$3.89M Buy
1,255,034
+96,631
+8% +$300K ﹤0.01% 2330
2023
Q1
$1.61M Sell
1,158,403
-38,138
-3% -$53K ﹤0.01% 2579
2022
Q4
$2.38M Buy
1,196,541
+6,945
+0.6% +$13.8K ﹤0.01% 2511
2022
Q3
$2.4M Buy
1,189,596
+23,282
+2% +$47K ﹤0.01% 2531
2022
Q2
$3.71M Sell
1,166,314
-14,332
-1% -$45.6K ﹤0.01% 2312
2022
Q1
$4.92M Buy
1,180,646
+19,009
+2% +$79.3K ﹤0.01% 2283
2021
Q4
$5.57M Buy
1,161,637
+15,374
+1% +$73.7K ﹤0.01% 2298
2021
Q3
$6.12M Buy
1,146,263
+49,813
+5% +$266K ﹤0.01% 2271
2021
Q2
$5.61M Buy
1,096,450
+210,536
+24% +$1.08M ﹤0.01% 2291
2021
Q1
$5.96M Buy
885,914
+157,112
+22% +$1.06M ﹤0.01% 2207
2020
Q4
$3.33M Buy
728,802
+701
+0.1% +$3.2K ﹤0.01% 2413
2020
Q3
$2.83M Sell
728,101
-26,915
-4% -$104K ﹤0.01% 2365
2020
Q2
$3.59M Buy
755,016
+48,210
+7% +$229K ﹤0.01% 2183
2020
Q1
$2.46M Buy
706,806
+15,068
+2% +$52.4K ﹤0.01% 2188
2019
Q4
$3.34M Buy
691,738
+129,741
+23% +$626K ﹤0.01% 2222
2019
Q3
$1.63M Sell
561,997
-143,660
-20% -$417K ﹤0.01% 2450
2019
Q2
$5.06M Buy
705,657
+33,072
+5% +$237K ﹤0.01% 1966
2019
Q1
$9.53M Buy
672,585
+81,666
+14% +$1.16M 0.01% 1630
2018
Q4
$8M Buy
590,919
+33,486
+6% +$453K 0.01% 1606
2018
Q3
$12.4M Buy
557,433
+141,429
+34% +$3.14M 0.01% 1486
2018
Q2
$6.83M Buy
+416,004
New +$6.83M 0.01% 1840